|
Australia-QLD-STRATHPINE Κατάλογοι Εταιρεία
|
Εταιρικά Νέα :
- EDGAR Filing Documents for 0001213900-25-014630 - SEC. gov
agreement and plan of merger and reorganization among the company, adaptin acqui: ea023016901ex2-1_adaptin htm: ex-2 1: 346852: 3: certificate of merger relating to the merger of adaptin acquisition co with and: ea023016901ex3-1_adaptin htm: ex-3 1: 20228: 4: amended and restated certificate of incorporation of unite acquisition 1 corp
- Form Technologies Acquired by Ares Management - PR Newswire
CHARLOTTE, N C , Jan 21, 2025 PRNewswire -- Form Technologies, Inc ("Form Technologies" or the "Company"), a global leader in the production of precision-engineered components, today
- Form Bio 2025 Company Profile: Valuation, Funding Investors - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Form Bio
- Form Bio - Overview, News Similar companies | ZoomInfo. com
View Form Bio (www formbio com) location in Texas, United States , revenue, industry and description Find related and similar companies as well as employees by title and much more
- Verde Bio Holdings, Inc. completed the acquisition of SensaSure . . .
Verde Bio Holdings, Inc entered into a non-binding letter of intent to acquire SensaSure Technologies, Inc in a reverse merger transaction on October 27, 2023 Verde Bio Holdings, Inc entered
- Form of Merger, Acquisition and other Business Arrangement Agreement
EX-10 16 21 dex1016 htm FORM OF MERGER, ACQUISITION AND OTHER BUSINESS ARRANGEMENT AGREEMENT Exhibit 10 16 HCFP BRENNER SECURITIES, LLC 888 Seventh Avenue, 17 th Floor New York, New York 10106 Agreement Regarding Mergers, Acquisitions and Other Business Arrangements (a) In the event that any acquisition of and or merger with other
- Ginkgo Bioworks Provides Compensation Information Related to Recent . . .
BOSTON, Feb 28, 2024 PRNewswire -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced that in connection to its
- sesn-20220920 - SEC. gov
In connection with the proposed Merger, Sesen Bio will file materials with the SEC, including the Registration Statement, which will include a document that serves as a proxy statement prospectus of Sesen Bio and an information statement of Carisma, and other documents regarding the proposed Merger
- Bristol-Myers Squibb Company agreed to acquire 2seventy bio, Inc. for . . .
Bristol-Myers Squibb Company (NYSE:BMY) agreed to acquire 2seventy bio, Inc (NasdaqGS:TSVT) for approximately $280 million on March 10, 2025 A cash consideration will be paid by Bristol-Myers Squibb Company at $5 per share
- 8-K - SEC. gov
On March 24, 2024, Nuvation Bio Inc , a Delaware corporation (“Nuvation Bio” or the “Company”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with AnHeart Therapeutics Ltd , an exempted company incorporated under the laws of the Cayman Islands (“AnHeart”), Artemis Merger Sub I, Ltd , an
|
|